| Literature DB >> 35201385 |
Kim Edmunds1, Paul Scuffham2, Robert U Newton3, Daniel A Galvão3, Haitham Tuffaha4.
Abstract
INTRODUCTION: Men who receive androgen deprivation therapy (ADT) for prostate cancer (PCa) are a vulnerable falls population due to the side effects of treatment. The purpose of this paper is to determine the cost-effectiveness of exercise in preventing falls and fractures for this high-risk population in Australia.Entities:
Keywords: Androgen deprivation therapy; Cost-utility analysis; Economic evaluation; Exercise medicine; Physical activity; Prostate cancer
Mesh:
Substances:
Year: 2022 PMID: 35201385 PMCID: PMC9046330 DOI: 10.1007/s00520-022-06900-2
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.359
Fig. 1State transition diagram
Model parameters
| Transition probabilities (12 months) | Distribution | Mean value | (95% CI) | Source |
|---|---|---|---|---|
| Fall in first year—control | Beta | 0.36 | (0.29, 0.43) | [ |
| Recurrent fall in same year | Beta | 0.65 | (0.53, 0.77) | [ |
| RR of fall in one year—exercise group | logNormal | 0.76 | (0.70, 0.81) | [ |
| One or more fall-related fractures—control | Beta | 0.12 | (0.09, 0.15) | [ |
| RR of one or more fall-related fractures—exercise | logNormal | 0.44 | (0.25, 0.76) | [ |
| Major fracture (MOF) | Beta | 0.62 | (0.58, 0.66) | [ |
| Minor fracture | Beta | 0.38 | (0.34, 0.42) | [ |
| Non-fracture injury | Beta | 0.88 | (0.87, 0.89) | [ |
| RR of non-fracture injury—exercise | logNormal | 0.70 | (0.54, 0.92) | [ |
| Major non-fracture injury | Beta | 0.06 | (0.055, 0.065) | [ |
| Minor non-fracture injury | Beta | 0.94 | (0.93, 0.95) | [ |
| Death from fall | Beta | 0.023 60–64yrs 0.043 65–69yrs 0.065 70–74yrs | (0.015, 0.031) (0.033, 0.053) (0.062, 0.068) | [ |
| Age-related mortality | Table 60–75 yrs | [ | ||
| Cost (12 months) | ||||
| Treatment major fracture | Gamma | $20,724 | (20,082, 21,366) | [ |
| Treatment for minor fracture | Gamma | $8,797 | (8,524, 9,070) | [ |
| Treatment major injury | Gamma | $10,040 | (9,729, 10,351) | [ |
| Treatment for minor injury (ED, non-admitted care, post discharge care) | Gamma | $1,115 | (1,080, 1,150) | [ |
| AEP supervised exercise intervention | Gamma | $767 | (743, 791) | [ |
| Utility | ||||
| Baseline pre-fracture/injury | Beta | 0.79 | (0.78, 0.80) | [ |
| Major fracture (MOF) | Beta | 0.475 | (0.47, 0.49) | [ |
| Minor fracture (‘non-hip, non-wrist, non-vertebral’) | Beta | 0.565 | (0.55, 0.59) | [ |
| Major fall injury (not fracture) | Beta | 0.47 | (0.46, 0.48) | [ |
| Minor fall injury/no injury (not fracture) | Beta | 0.765 | (0.76, 0.80) | [ |
| Recurrent fall (FOF) | Beta | 0.72 | (0.70, 0.74) | [ |
| Recurrent fall exercise (FOF) | Beta | 0.74 | (0.72, 0.76) | [ |
Abbreviations: RR., relative risk; MOF, major osteoporotic fracture—hip, vertebrae, upper or lower arm; ED, emergency department; AEP, accredited exercise physiologist; FOF, fear of falling
Cost of exercise intervention (AU$2019)
| Intervention cost component | Cost description | Unit of measure | Cost per participant |
|---|---|---|---|
| GP consent | MBS Item 23: Level B GP consultation lasting less than 20 min (2019) | 1 consultation ($38.20) | $38 |
| Registration of intervention participants & administration | Clerks private sector award 2010 level 3 $911/week ($23.97/h) + 20% on costs (2019) | 30-min clerk time + phone calls | $15 |
| AEP pre-program consultation | MBS Item no. 81110 | 1 consultation | $81 |
| Subtotal | $134 | ||
| 50-week exercise intervention | 1-h exercise session AEP MBS Item no. 10953 | Up to 10 participants per session | $633 |
| Total per participant (healthcare perspective) | $767 | ||
Abbreviations: GP, general practitioner; MBS, Medicare benefits schedule; RCT, randomised controlled trial; AEP, accredited exercise physiologist
Results modelled CUA of supervised exercise intervention (12 months)
| Variable | Control group | Intervention group | Difference | NMB | iNMB | |
|---|---|---|---|---|---|---|
| Mean cost | $4,135 | $2,952 | $1,183 | Control | $ 99,101 | $3,010 |
| Mean QALYs | 2.06 | 2.10 | 0.04 | Intervention | $102,112 | |
Abbreviations: NMB, net monetary benefit; iNMB, incremental net monetary benefit; QALYs, quality-adjusted life years
Fig. 2Univariate sensitivity analyses. Legend Lower value of parameter Higher value of parameter
Fig. 3Cost-effectiveness acceptability curve